%0 Journal Article
%T 血液标志物对预测重症急性胰腺炎继发ARDS的应用进展<br>Advances in the Application of Blood Biomarkers for Predicting ARDS Secondary to Severe Acute Pancreatitis
%A 吴素素
%A 孙强
%J Journal of Clinical Personalized Medicine
%P 8-15
%@ 2334-3443
%D 2025
%I Hans Publishing
%R 10.12677/jcpm.2025.43309
%X 重症急性胰腺炎(SAP)是急性胰腺炎(AP)最严重的类型&#65292;具有发病迅速、病情危重、进展快等特点。并发急性呼吸窘迫综合征(ARDS)时显著增加了病死率。早期识别并发ARDS高风险患者是降低病死率的关键&#65292;本文旨在系统回顾血液标志物对预测SAP合并ARDS的研究进展&#65292;为临床早期识别和干预提供依据。<br>Severe acute pancreatitis (SAP), the most critical form of acute pancreatitis (AP), is characterized by abrupt onset, severe progression, and rapid deterioration. The development of acute respiratory distress syndrome (ARDS) significantly increases mortality. Early identification of high-risk patients prone to ARDS is crucial for reducing fatality rates. This article systematically reviews research advances in blood-based biomarkers for predicting ARDS in SAP, aiming to provide a foundation for early clinical recognition and intervention.
%K 重症急性胰腺炎&#65292
%K ARDS&#65292
%K 预测因子&#65292
%K 综述<br>Severe Acute Pancreatitis
%K ARDS
%K Predictive Factors
%K Review
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=113217